# Animal Genetics Market

> Animal Genetics Market Research Report: Size, Share, Trend Analysis By Products (Genetic Materials, Live Animals, and Others), By Services (Genetic Disease Tests, DNA Typing, and Gene Trait Tests), By End Userss (Veterinary Hospitals & Clinics and Diagnostic Centers), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 6.52%
- **2025:** USD 6.54 Billion
- **2035:** USD 12.04 Billion
- **Key Players:** Genus plc (ABS, PIC), Hendrix Genetics, EW Group (Aviagen, Hy-Line), URUS Group (CRV, Alta, GENEX), Neogen Corporation, Zoetis Inc., Topigs Norsvin, Groupe Grimaud

**Report ID:** MRFR/LS/5539-HCR · **Pages:** 90 · **Author:** Rahul Gotadki & Vikita Thakur · **Last Updated:** October 27, 2026

**URL:** https://www.marketresearchfuture.com/reports/animal-genetics-market-7004

---

## Market Summary

## Animal Genetics Market Summary

The Animal Genetics Market reached USD 6.54 billion in 2025 and opens the forecast window at USD 6.81 billion in 2026, advancing to USD 12.04 billion by 2035 at a 6.52% CAGR. Two catalysts anchor that trajectory. The USDA Agricultural Research Service sustained roughly USD 1.9 billion in annual in-house research funding across food animal production programs, a share of which underwrites genomic selection reference populations [1]. The FAO's Global Plan of Action for Animal Genetic Resources, adopted by 109 countries, obliges signatories to maintain breed characterization and cryoconservation programs, which converts genetic recordkeeping from a discretionary cost into a reporting obligation [2].

Selection methodology inside the Animal Genetics Market is being rebuilt. Pedigree-and-progeny testing — a system that required four to six years to validate a dairy sire — is giving way to genomic estimated breeding values derived from 50K–777K SNP arrays that return a reliability score within weeks. Sequencing economics made the substitution viable: per-genome costs fell from roughly USD 10,000 in 2011 to under USD 200 by 2024 [3]. The European Commission committed EUR 8.9 billion to Horizon Europe Cluster 6, which funds livestock genomics and [animal health](https://www.marketresearchfuture.com/reports/animal-health-market-7163) resilience work [4].

North America holds 37.1% of the Animal Genetics Market on the strength of integrated poultry and swine operations and a dense laboratory network. Asia-Pacific grows fastest at 7.94% CAGR as China's dairy consolidation and India's Rashtriya Gokul Mission scale [artificial insemination](https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218) coverage. Europe follows at 28.4%, supported by breed association datasets that stretch back decades. Genomic infrastructure built this decade will define competitive position in the next.

## Key Report Takeaways

### • By Product Type (Value)

- Live animals commanded 58.4% of Animal Genetics Market revenue in 2025, sustained by buyer willingness to pay premiums for validated sires
- Genetic material — semen, embryos, DNA libraries — advances at 7.20% CAGR as vitrification lifts post-thaw viability above 90%

### • By Testing Service Type (Value)

- Genetic trait and performance testing generated USD 3.34 billion in 2025, the largest service pool in the Animal Genetics Market
- DNA typing and parentage testing posts 7.25% CAGR on falling per-sample sequencing costs

### • By Technology (Value)

- Artificial insemination delivered 52.9% of 2025 revenue across bovine, porcine and ovine herds
- CRISPR and gene editing records the fastest 7.88% CAGR despite a modest current base

### • By End User (Value)

- Breeding companies and associations held 35.6% of revenue, backed by proprietary lines and global distribution
- Veterinary hospitals and clinics expand at 8.15% CAGR as genomic diagnostics enter routine care

### • By Region

- North America contributed USD 2.43 billion in 2025, the largest regional pool
- Asia-Pacific compounds at 7.94% through 2035, the fastest of any region
- Europe holds a 28.4% share, anchored by long-running breed association pedigree databases

## Market Size and Forecast (2021–2035)

Sizing combines bottom-up revenue modelling of semen and embryo unit volumes, laboratory test throughput, and breeding stock transaction values, triangulated against company filings, FAO livestock census data, and national herd registries. Historical years are reconstructed from audited revenue disclosures of the ten largest participants and regulatory trade statistics; forecast years apply species-level herd growth assumptions to per-head genetic spend.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Collapsing sequencing and genotyping costs | 1.5 | Global | Short-term (≤2 yr) | [3] |
| Protein demand growth in emerging economies | 1.2 | Asia-Pacific, South America | Long-term (≥4 yr) | [10] |
| Government artificial insemination programs | 1.0 | Asia-Pacific, MEA | Medium-term (2–4 yr) |  |
| Disease resistance breeding mandates | 0.9 | Europe, North America | Medium-term (2–4 yr) | [12] |
| Dairy and swine operation consolidation | 0.8 | Global | Long-term (≥4 yr) | [13] |
| Companion animal genomic diagnostics | 0.7 | North America, Europe | Short-term (≤2 yr) | [14] |
| Feed conversion efficiency economics | 0.6 | Global | Long-term (≥4 yr) | [15] |

### Collapsing Sequencing and Genotyping Costs

By 2024, per-sample genotyping on mid-density bovine SNP arrays was less than USD 30, compared to about USD 250 ten years prior [3]. Genomic testing shifted from elite seedstock to commercial herds as a result of this reduction. Through the Council on Dairy Cattle Breeding, US dairy farmers now genotype more than 500,000 heifers each year, and the reference population has more than 8 million animals. This scale directly improves breeding value reliability and increases the value of each subsequent test.

### Protein Demand Growth in Emerging Economies

In comparison to a 2020 baseline, FAO predicts that worldwide meat consumption would increase by 14% by 2030, with nearly all of the additional volume occurring in low- and middle-income nations [10]. Growth in output must come from per-animal productivity if producers are unable to increase land area proportionately. Vietnamese, Brazilian, and Indonesian integrators have shifted to imported grandparent stock and structured selection indices because genetic improvement accounts for almost half of the realized productivity gain in intensive poultry systems.

### Government Artificial Insemination Programs

India's Rashtriya Gokul Mission received INR 2,400 crore under the 2021–2026 plan cycle and has delivered free artificial insemination to more than 80 million animals across 605 districts . Ethiopia, Kenya and Pakistan run analogous schemes with World Bank co-financing. These programs build technician networks and liquid nitrogen distribution infrastructure that private semen suppliers subsequently use, converting public spend into durable commercial channel capacity.

### Disease Resistance Breeding Mandates

The European Union's Animal Health Law, Regulation 2016/429, requires member states to operate surveillance and eradication programs for listed diseases, pushing breeders toward genetically resistant lines [12]. Scrapie-resistant genotype selection in sheep, mandatory under UK and EU national plans, established the template. PRRS-resistant swine and avian influenza tolerance in poultry now follow the same regulatory logic, with resistance markers embedded directly into commercial selection indices.

### Dairy and Swine Operation Consolidation

USDA census data shows US dairy operations fell from 39,300 in 2017 to under 24,500 by 2024 while total cow numbers held near 9.3 million [13]. Larger units justify dedicated reproduction staff, on-farm sensors, and structured genetic programs that 60-cow herds could not. Average genetic spend per head rises roughly 2.5 times when herd size crosses 1,000 animals, so consolidation mechanically lifts addressable revenue without any change in underlying technology.

### Companion Animal Genomic Diagnostics

Breed-specific hereditary disease panels now screen for over 250 variants in dogs, and uptake among US veterinary practices reached an estimated 18% of clinics offering in-house genetic screening by 2024 [14]. The expanded 21,000-square-foot UC Davis Veterinary Genetics Laboratory processes tens of thousands of samples monthly at turnaround times supporting same-week clinical decisions. This channel carries higher gross margins than livestock testing and grows independently of agricultural commodity cycles.

### Feed Conversion Efficiency Economics

Feed represents 60–70% of broiler production cost, so a 0.01 improvement in feed conversion ratio saves an integrator processing 500 million birds annually roughly USD 12 million [15]. Genetic selection has cut broiler FCR from 2.0 to below 1.55 over three decades. With soybean meal and maize prices volatile since 2022, integrators treat residual feed intake selection as a hedge rather than an optimization, which sustains genetic spend through commodity downturns.

## Restraints

## Restraints Impact Analysis

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Gene-editing regulatory uncertainty | -0.9 | Europe, Asia-Pacific | Medium-term (2–4 yr) | [16] |
| Smallholder capital constraints | -0.7 | Asia-Pacific, MEA | Long-term (≥4 yr) | [17] |
| Genetic diversity erosion concerns | -0.5 | Global | Long-term (≥4 yr) | [2] |
| Cold chain and logistics failure rates | -0.4 | MEA, South America | Short-term (≤2 yr) | [18] |
| Data ownership disputes between breeders and platforms | -0.3 | North America, Europe | Medium-term (2–4 yr) | [19] |

### Gene-Editing Regulatory Uncertainty

Gene-edited creatures were placed under Directive 2001/18/EC by the Court of Justice of the European Union's 2018 judgment, and animals are still not included in the New Genomic Techniques proposal, which was proposed in July 2023 [16]. As a result, developers are unable to sell modified cattle to 450 million people. European investment is stifled by this imbalance against the United States, which authorized gene-edited pork in 2025.

### Smallholder Capital Constraints

A significant portion of the world's livestock is kept on 500 million smallholder farms, according to estimates, yet the median annual household income in these systems is less than USD 2,500 [17]. In contrast to unclear conception rates, a USD 25 semen straw plus technician cost is a material expenditure. Genetic upgrading stops at the point where it would yield the largest proportionate productivity gain in the absence of subsidies or cooperative aggregation.

### Genetic Diversity Erosion Concerns

FAO's Domestic Animal Diversity Information System classifies 26% of reported livestock breeds as at risk of extinction, with intensive selection on narrow elite lines a documented contributor [2]. Holstein effective population size has fallen below 50 in some national herds. Regulators and breed associations increasingly impose inbreeding coefficient ceilings, which constrain how aggressively suppliers can market top-ranked sires.

### Cold Chain and Logistics Failure Rates

Frozen semen and embryos require uninterrupted liquid nitrogen at -196°C. Field audits in sub-Saharan artificial insemination programs have recorded conception rates 15–20 percentage points below temperate benchmarks, with tank failure and thaw mishandling the leading causes [18]. Each failed insemination destroys the product's value and damages producer confidence, slowing repeat purchase in precisely the markets with the largest untapped herd base.

### Data Ownership Disputes Between Breeders and Platforms

Genomic evaluations depend on pooled phenotype data, but producers increasingly contest who owns performance records uploaded to proprietary herd management platforms. US litigation and European Data Act provisions applying from September 2025 have forced renegotiation of contributor agreements [19]. Where terms remain unsettled, producers withhold records, thinning the reference populations that make evaluations accurate.

## Opportunities

## Animal Genetics Market Opportunities

### Sexed Semen Penetration in Emerging Dairy Systems

Sexed semen now exceeds 70% of dairy inseminations in the United States but remains under 15% across most of South and Southeast Asia. Flow cytometry throughput improvements and licensing arrangements have cut the price premium over conventional straws from roughly 3x to 1.7x. For a smallholder with three cows, guaranteeing heifer replacements materially changes herd economics. Suppliers that pair sexed product with financing and technician training capture a channel competitors cannot easily replicate.

### Aquaculture Genetics as an Underbuilt Category

Farmed fish supply over half of aquatic food consumed globally, yet fewer than 10% of aquaculture species have structured breeding programs. Atlantic salmon demonstrates the prize: four decades of selection roughly doubled growth rate and cut production cycles. Tilapia, shrimp, and pangasius programs remain early-stage. Genomic selection applied to disease resistance in shrimp, where white spot syndrome causes billions in annual loss, represents the clearest near-term commercial opening.

### Data Monetization Through Genomic Subscription Platforms

Laboratories historically sold discrete tests. The emerging model licenses ongoing access to evaluation engines, benchmarking dashboards, and mating allocation algorithms for a per-cow annual fee. Recurring revenue carries higher multiples than transactional testing and lifts switching costs sharply, because a producer who exports raw genotypes still loses the comparative benchmarks. Companies building proprietary phenotype pools alongside genotype libraries create a data asset competitors cannot buy.

### Methane-Efficiency Trait Selection

New Zealand and Ireland have added methane-related traits to national breeding indices, and low-emission sires show measurable heritability around 0.20. With agricultural emissions entering national inventories and carbon markets, a genetic route to reduction that costs nothing per animal after selection is commercially distinctive. Breeding companies that build methane phenotype reference populations first will hold a durable advantage as reporting obligations tighten across the EU and Oceania.

### African Livestock Genetic Upgrading

Sub-Saharan Africa holds roughly 350 million cattle, producing a fraction of temperate per-animal output. Crossbreeding programs pairing indigenous heat and disease tolerance with exotic productivity — rather than wholesale breed replacement — have shown durable results in Ethiopia and Tanzania. Donor-funded infrastructure creates the distribution backbone; commercial suppliers then sell into an established channel. The gap is large enough that even modest penetration shifts regional totals.

## Future Outlook

## Animal Genetics Market Future Outlook

### Machine Learning in Genomic Prediction

Linear mixed models have carried genomic selection for fifteen years, but they capture additive effects poorly when marker density reaches whole-genome resolution. Deep learning approaches trained on combined genotype, phenotype, and environmental datasets show accuracy gains of 3–8% for complex traits in published trials. With whole-genome sequencing costs now under USD 200 per animal [3], reference populations will shift from array genotypes to sequence data across the forecast period, and the computational method becomes the differentiator rather than the assay.

### Gene Editing Moves From Trials to Herds

Commercial precedent now exists. Field trials with BMPRIB-edited fine-wool sheep achieved 47.4% editing efficiency with measurably higher litter sizes, and United States regulators cleared gene-edited pork for market. Disease resistance is the first commercial application because it addresses losses producers already quantify — PRRS alone costs North American swine producers over USD 1.2 billion annually . Adoption speed depends less on the biology than on labelling policy and consumer acceptance in export destination markets.

### Sustainability Reporting Pulls Genetics Into Scope

Agriculture accounts for roughly 12% of global greenhouse gas emissions on IPCC accounting, with enteric fermentation the dominant livestock source. As the EU Corporate Sustainability Reporting Directive extends Scope 3 disclosure into food supply chains, processors will demand emissions data from suppliers. Breeding indices that weight feed efficiency and methane traits offer permanent, cumulative reduction rather than annual operational adjustment, which makes genetics unusually attractive against alternatives requiring continuous input spend.

### Consolidation Reshapes the Supplier Base

The Animal Genetics Market retains medium concentration, but the economics favor scale: reference population size directly determines evaluation accuracy, and accuracy determines product performance. That creates a reinforcing advantage larger players compound each cycle. Expect continued acquisition of species specialists and laboratory networks by diversified animal health groups seeking to bundle genetics with nutrition and pharmaceuticals. Regional champions in Brazil, India, and China represent the most likely acquisition targets through 2030.

## Segment Insights

## Animal Genetics Market Segmentation

### By Product Type (Value)

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Live Animals | 58.4% share (2025) | Buyer premium for proven sires with validated production records |
| Genetic Material | 7.20% CAGR | Cryopreservation advances and digital germplasm ordering |

Live animals remain the revenue anchor because commercial buyers pay heavily for demonstrated on-farm performance, with elite sires transacting above USD 50,000. Improved quarantine and logistics infrastructure has simplified cross-border movement of breeding stock. Genetic material grows faster: embryo vitrification now delivers post-thaw viability above 90%, letting emerging-market dairies achieve rapid genetic gain without importing live cattle. Semen carries volume; premium embryos and DNA libraries carry margin.

### By Testing Service Type (Value)

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Genetic Trait Tests | USD 3.34 B (2025) | Selection index refinement across milk yield, carcass, and feed traits |
| DNA Typing and Parentage Testing | 7.25% CAGR | Falling sequencing costs and mail-in collection kits |
| Genetic Disease Testing | 6.10% CAGR | Breed-specific hereditary screening in companion animals and seedstock |

Genetic trait testing leads because integrated pork and poultry operations compound small feed efficiency gains across millions of head, making the service economics unambiguous. Cloud dashboards now return real-time benchmarking each breeding cycle. DNA typing grows fastest as per-sample costs collapse and handheld collection kits reach clinics; laboratories bundle typing with trait panels to upsell analytics. Genetic disease testing tracks companion animal demand, where hereditary variant panels have become standard practice in specialty veterinary care.

### By Technology (Value)

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Artificial Insemination (AI) | 52.9% share (2025) | Cost-effective propagation of desirable genetics across large herds |
| Embryo Transfer (ET) | USD 1.21 B (2025) | Multiplication of elite female genetics in dairy and beef |
| CRISPR and Gene Editing | 7.88% CAGR | Disease resistance traits and regulatory clearance in the United States |

### By End User (Value)

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Breeding Companies & Associations | 35.6% share (2025) | Proprietary lines, R&D pipelines and global distribution networks |
| Livestock Producers/Farms | USD 2.09 B (2025) | Direct genetic procurement by consolidated dairy and swine operations |
| Veterinary Hospitals and Clinics | 8.15% CAGR | Integration of genomic diagnostics into routine health management |

Breeding companies and associations lead on scale, and many now bundle scenario-modelling software that raises client switching costs before a straw is purchased. Consolidation continues as firms buy species coverage or editing capability. Veterinary hospitals and clinics grow fastest: laboratory expansion — the UC Davis facility now runs tens of thousands of samples monthly — supports same-week clinical decisions, pulling genetic testing into standard practice well beyond traditional breeding operations.

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Metric | Primary Investment Themes |
| --- | --- | --- |
| North America | USD 2.43 B (2025) | Genomic dairy evaluation, gene-edited swine, companion animal panels |
| Europe | 28.4% share | Breed association datasets, disease resistance breeding, methane traits |
| Asia-Pacific | 7.94% CAGR | Public artificial insemination schemes, dairy consolidation, poultry integration |
| South America | USD 0.62 B (2025) | Beef genetics export, tropical adaptation traits |
| Middle East & Africa | 5.9% share | Crossbreeding programs, donor-funded infrastructure |
| Total | USD 6.54 B (2025) | — |

Regional distribution in the Animal Genetics Market reflects herd structure, laboratory density, and the maturity of national recording schemes rather than livestock population alone.

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| United States | 84.2% of region | Dense genomic evaluation infrastructure and integrated swine and poultry operations |

United States leadership rests on institutional scale rather than herd size. The Council on Dairy Cattle Breeding maintains genomic evaluations on a reference population exceeding 8 million animals, giving domestic breeding values reliability levels no other national system matches. FDA's 2025 approval pathway for gene-edited swine established the first major regulatory green light for edited food animals, and USDA Agricultural Research Service programs continue funding phenotype collection that private breeders could not economically replicate on their own [1].

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| Rest of Europe | 28.4% of global market | Long-horizon breed association pedigree databases and EU animal health regulation |

European strength derives from data depth. Scandinavian and Dutch recording schemes hold continuous performance records stretching back decades, which supports evaluation of low-heritability traits such as fertility and health that shorter datasets cannot resolve. Horizon Europe Cluster 6 directs EUR 8.9 billion toward food, bioeconomy and agriculture research, with livestock [genomics](https://www.marketresearchfuture.com/reports/genomics-market-12283) a recurring call topic [4]. Regulatory exclusion of edited animals, however, redirects European investment toward conventional genomic selection.

### Asia-Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| Rest of Asia-Pacific | 7.94% CAGR | State artificial insemination programs and rapid dairy and swine consolidation |

Asia-Pacific growth is policy-led. India's Rashtriya Gokul Mission has extended free artificial insemination coverage to over 80 million animals and built a technician network numbering in the tens of thousands . China's post-African swine fever rebuild replaced fragmented backyard production with integrated units running structured genetic programs, permanently raising per-head genetic spend. Vietnamese and Indonesian poultry integrators import grandparent stock at scale, embedding dependence on external genetic supply.

### South America

| Country | Metric | Key Driver |
| --- | --- | --- |
| Rest of South America | USD 0.62 B (2025) | Beef cattle genetics and tropical adaptation trait selection |

Brazil anchors the region with the world's largest commercial cattle herd and a Nelore genetic improvement program that has run structured performance recording since the 1980s. Embrapa's breeding work on tropical adaptation — heat tolerance, tick resistance, forage efficiency — produces genetics with export value into Africa and Southeast Asia. Argentine and Uruguayan beef exporters increasingly use genomic testing to certify marbling and tenderness for premium Asian buyers, adding a traceability dimension to genetic spend.

### Middle East & Africa

| Country | Metric | Key Driver |
| --- | --- | --- |
| Rest of Middle East & Africa | 5.9% of global market | Donor-financed crossbreeding schemes and dairy import substitution |

Gulf states pursue dairy self-sufficiency through large intensive units importing elite Holstein genetics, with Saudi Arabia's Almarai operating herds exceeding 90,000 head under climate-controlled conditions. Sub-Saharan activity follows a different logic, centered on crossbreeding programs that retain indigenous disease and heat tolerance. Cold chain reliability remains the binding constraint; field conception rates trail temperate benchmarks by 15–20 percentage points where liquid nitrogen distribution is intermittent [18].

## Competitive Benchmarking

## Competitive Benchmarking

Concentration sits in the medium band. The top five participants hold an estimated 38–44% of global revenue, producing an HHI in the 550–750 range — competitive by antitrust standards, but with a clear tier structure. Scale matters asymmetrically: reference population size determines evaluation accuracy, so leaders compound advantage each breeding cycle. Fragmentation persists at the species and regional level, where poultry, aquaculture, and companion animal specialists operate largely outside the bovine mainstream.

| Company | Est. Revenue Share Range | Key Offerings for Animal Genetics Market | Strategic Positioning |
| --- | --- | --- | --- |
| Genus plc (ABS, PIC) | ~11–14% | Bovine semen, porcine breeding stock, sexed genetics | Dual-species scale leader with gene-editing pipeline |
| Hendrix Genetics | ~7–9% | Layer, turkey, swine, aquaculture breeding programs | Broadest species portfolio among private players |
| EW Group (Aviagen, Hy-Line) | ~7–9% | Broiler and layer grandparent stock | Poultry genetics incumbent with global hatchery reach |
| URUS Group (CRV, Alta, GENEX) | ~5–7% | Bovine genetics, herd management data services | Cooperative-rooted network with strong data assets |
| Neogen Corporation | ~4–6% | Genomic testing, DNA typing, food safety diagnostics | Laboratory-led model spanning livestock and companion animals |
| Zoetis Inc. | ~4–6% | Precision livestock genomics, companion animal diagnostics | Animal health platform bundling genetics with therapeutics |
| Topigs Norsvin | ~3–5% | Porcine breeding programs and boar semen | Swine specialist with strong European and Brazilian presence |
| Groupe Grimaud | ~3–4% | Waterfowl, rabbit and specialty poultry genetics | Niche species leader with biopharma adjacency |
| Alltech (Coppens, ETALON) | ~2–4% | Equine and livestock genotyping services | Nutrition-plus-genetics integration play |
| VetGen / Mars Petcare (Wisdom Panel) | ~2–4% | Companion animal DNA panels and hereditary screening | Consumer-facing genomics with clinical channel expansion |

## Recent News & Developments

## Recent News & Developments

- US Food and Drug Administration (April 2025): Cleared gene-edited swine carrying PRRS resistance for the food supply, the first such approval for a major livestock species and a template for subsequent editing submissions .
- Genus plc (October 2024): Reported regulatory progress on its PRRS-resistant pig programme across multiple export markets, advancing the commercial timeline for edited breeding stock distribution .
- Neogen Corporation (June 2024): Expanded genomic testing capacity at its Lincoln, Nebraska laboratory, targeting faster turnaround for large-herd bovine genotyping contracts [14].
- European Commission (July 2023): Tabled the New Genomic Techniques regulation covering plants but excluding animals, preserving the existing GMO framework for edited livestock across the bloc [16].
- Hendrix Genetics (March 2024): Announced expansion of its shrimp breeding programme in Latin America, targeting white spot syndrome resistance traits for commercial hatchery customers [20].
- Government of India (February 2024): Reported the Rashtriya Gokul Mission surpassing 80 million animals covered under nationwide free artificial insemination, with coverage extended across 605 districts .
- Zoetis Inc. (September 2023): Launched an expanded precision livestock genomics offering integrating genotype results with herd health monitoring data for dairy clients [21].
- UC Davis Veterinary Genetics Laboratory (May 2024): Opened a 21,000-square-foot expanded facility capable of processing tens of thousands of diagnostic samples monthly for companion and production animals [14].

## Report Scope

| Report Attribute/Metric | Details |
| --- | --- |
| Market Scope | Global animal genetics products and services spanning live breeding animals, genetic material, testing services, and reproductive technologies across bovine, porcine, poultry, ovine, aquaculture, and companion animals |
| Study Period | 2021-2035 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2035 |
| Market Size in 2025 | USD 6.54 Billion |
| Market Size in 2035 | USD 12.04 Billion |
| CAGR (2026–2035) | 6.52% |
| Fastest Growing Segments | Genetic Material (7.20% CAGR); CRISPR and Gene Editing (7.88% CAGR); Veterinary Hospitals and Clinics (8.15% CAGR); Asia-Pacific (7.94% CAGR) |
| Regions Covered | Asia-Pacific (7.94% CAGR); North America, Europe, APAC, South America, MEA |
| Companies Profiled | Genus plc, Hendrix Genetics, EW Group, URUS Group, Neogen Corporation, Zoetis Inc., Topigs Norsvin, Groupe Grimaud, Alltech, VetGen / Mars Petcare |
| Valuation Currency | USD Billion |
| Methodology | Triangulated approach: top-down (manufacturer revenue), bottom-up (unit shipment × ASP), econometric (housing starts, hospitality pipeline correlation) |

## Frequently Asked Questions

**Q: How should a buyer evaluate vendors in the Animal Genetics Market beyond price per straw?**
A: Reference population size and phenotype depth determine evaluation reliability more than list price. Ask for reliability percentages on the specific traits you select for, not aggregate index figures [22].

**Q: What contractual terms matter most when signing a genomic testing agreement?**
A: Data ownership and portability clauses. Confirm you can export raw genotypes and retain rights to phenotype records if you switch providers, since European Data Act provisions now support that position [19].

**Q: How does the Animal Genetics Market treat intellectual property in breeding lines?**
A: Protection relies on trade secrecy and terminal-cross structures rather than patents for conventional genetics. Gene-edited traits are patentable, which is shifting competitive strategy toward editing portfolios [9].

**Q: What integration problems arise when adding genomic data to existing herd software?**
A: Identifier mismatches between laboratory sample codes and on-farm animal IDs cause most failures. Resolve tagging conventions before the first batch ships, or reconciliation costs exceed the testing spend [21].

**Q: Is embryo transfer worth the cost premium over artificial insemination for mid-sized herds?**
A: Only where individual female genetic merit justifies multiplication — typically the top 5% of a herd. Below that threshold, conventional insemination with sexed semen delivers better return per dollar.

**Q: How do investors assess risk in the Animal Genetics Market given commodity cycle exposure?**
A: Recurring testing and service revenue proves more cycle-resistant than live animal sales. Companion animal diagnostics exposure further decouples earnings from agricultural commodity prices [14].

**Q: What regulatory nuance should exporters of genetic material watch most closely?**
A: Destination-market rules on gene-edited progeny differ sharply from origin-market approvals. Product cleared in the United States may be blocked in the European Union, stranding inventory mid-chain [16].


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/animal-genetics-market-7004*